Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.
Billionaire investor Stanley Druckenmiller, who runs Duquesne Family Office, has tapped the brakes on his Nvidia investment as he believes the artificial intelligence revolution has gone too far too fast.
The prospect of Donald Trump returning to the presidency might significantly bolster the cryptocurrency sector, according to a recent research report by Standard Chartered.
Intel partners with 14 Japanese companies to develop automation tech for semiconductor processes. Microsoft plans $2.9B investment in Japanese data centers, TSMC to source materials locally, Amazon to invest $15.5B in data centers and business operations.
Johnson & Johnson unveils promising TARIS platform data for bladder cancer treatment, highlighting ease of administration and significant revenue potential.